Literature DB >> 26824597

Hypophosphatemic rickets and craniosynostosis: a multicenter case series.

Rafael A Vega1, Charles Opalak1, Raymond J Harshbarger2, Jeffrey A Fearon3, Ann M Ritter1, John J Collins1, Jennifer L Rhodes4.   

Abstract

OBJECTIVE This study examines a series of patients with hypophosphatemic rickets and craniosynostosis to characterize the clinical course and associated craniofacial anomalies. METHODS A 20-year retrospective review identified patients with hypophosphatemic rickets and secondary craniosynostosis at 3 major craniofacial centers. Parameters examined included sex, age at diagnosis of head shape anomaly, affected sutures, etiology of rickets, presenting symptoms, number and type of surgical interventions, and associated diagnoses. A review of the literature was performed to optimize treatment recommendations. RESULTS Ten patients were identified (8 males, 2 females). Age at presentation ranged from 1 to 9 years. The most commonly affected suture was the sagittal (6/10 patients). Etiologies included antacid-induced rickets, autosomal dominant hypophosphatemic rickets, and X-linked hypophosphatemic (XLH) rickets. Nine patients had undergone at least 1 cranial vault remodeling (CVR) surgery. Three patients underwent subsequent surgeries in later years. Four patients underwent formal intracranial pressure (ICP) monitoring, 3 of which revealed elevated ICP. Three patients were diagnosed with a Chiari Type I malformation. CONCLUSIONS Secondary craniosynostosis develops postnatally due to metabolic or mechanical factors. The most common metabolic cause is hypophosphatemic rickets, which has a variety of etiologies. Head shape changes occur later and with a more heterogeneous presentation compared with that of primary craniosynostosis. CVR may be required to prevent or relieve elevated ICP and abnormalities of the cranial vault. Children with hypophosphatemic rickets who develop head shape abnormalities should be promptly referred to a craniofacial specialist.

Entities:  

Keywords:  CM = Chiari malformation; CM-I = CM Type I; CVR = cranial vault remodeling; FGF23 = fibroblast growth factor 23; ICP = intracranial pressure; XLH = X-linked hypophosphatemic; craniofacial surgery; craniosynostosis; hypophosphatemia; rickets

Mesh:

Year:  2016        PMID: 26824597     DOI: 10.3171/2015.10.PEDS15273

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  15 in total

1.  The first Korean case report with scaphocephaly as the initial sign of X-linked hypophosphatemic rickets.

Authors:  Keun Soo Lee; Bo Lyun Lee
Journal:  Childs Nerv Syst       Date:  2019-01-06       Impact factor: 1.475

Review 2.  Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.

Authors:  Andrea Trombetti; Nasser Al-Daghri; Maria Luisa Brandi; Jorge B Cannata-Andía; Etienne Cavalier; Manju Chandran; Catherine Chaussain; Lucia Cipullo; Cyrus Cooper; Dieter Haffner; Pol Harvengt; Nicholas C Harvey; Muhammad Kassim Javaid; Famida Jiwa; John A Kanis; Andrea Laslop; Michaël R Laurent; Agnès Linglart; Andréa Marques; Gabriel T Mindler; Salvatore Minisola; María Concepción Prieto Yerro; Mario Miguel Rosa; Lothar Seefried; Mila Vlaskovska; María Belén Zanchetta; René Rizzoli
Journal:  Nat Rev Endocrinol       Date:  2022-04-28       Impact factor: 43.330

3.  Premature Fusion of the Sagittal Suture as an Incidental Radiographic Finding in Young Children.

Authors:  Monica Manrique; Esperanza Mantilla-Rivas; Antonio R Porras Perez; Justin R Bryant; Md Sohel Rana; Liyun Tu; Robert F Keating; Albert K Oh; Marius G Linguraru; Gary F Rogers
Journal:  Plast Reconstr Surg       Date:  2021-10-01       Impact factor: 5.169

4.  Normocephalic sagittal craniosynostosis in young children is common and unrecognized.

Authors:  M Manrique; E Mantilla-Rivas; M S Rana; H Crowder; N Oh; A K Oh; R F Keating; G F Rogers
Journal:  Childs Nerv Syst       Date:  2022-06-18       Impact factor: 1.532

5.  Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia.

Authors:  Olaya Hernández-Frías; Helena Gil-Peña; José M Pérez-Roldán; Susana González-Sanchez; Gema Ariceta; Sara Chocrón; Reyner Loza; Francisco de la Cerda Ojeda; Leire Madariaga; Inés Vergara; Marta Fernández-Fernández; Susana Ferrando-Monleón; Montserrat Antón-Gamero; Ángeles Fernández-Maseda; M Isabel Luis-Yanes; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

Review 6.  Pharmacological management of X-linked hypophosphataemia.

Authors:  Erik A Imel; Kenneth E White
Journal:  Br J Clin Pharmacol       Date:  2018-10-29       Impact factor: 4.335

Review 7.  FGF23 and its role in X-linked hypophosphatemia-related morbidity.

Authors:  Signe Sparre Beck-Nielsen; Zulf Mughal; Dieter Haffner; Ola Nilsson; Elena Levtchenko; Gema Ariceta; Carmen de Lucas Collantes; Dirk Schnabel; Ravi Jandhyala; Outi Mäkitie
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

Review 8.  Dental-craniofacial manifestation and treatment of rare diseases.

Authors:  En Luo; Hanghang Liu; Qiucheng Zhao; Bing Shi; Qianming Chen
Journal:  Int J Oral Sci       Date:  2019-02-20       Impact factor: 6.344

Review 9.  FGF23, Hypophosphatemia, and Emerging Treatments.

Authors:  Erik A Imel; Andrew Biggin; Aaron Schindeler; Craig F Munns
Journal:  JBMR Plus       Date:  2019-05-13

10.  Syndromic and Systemic Diagnoses Associated With Isolated Sagittal Synostosis.

Authors:  Amani A Davis; Mostafa M Haredy; Jennifer Huey; Hannah Scanga; Giulio Zuccoli; Ian F Pollack; Mandeep S Tamber; Jesse Goldstein; Suneeta Madan-Khetarpal; Ken K Nischal
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.